Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer
- 1 July 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (11) , 1533-1541
- https://doi.org/10.1016/j.ejca.2005.03.026
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- [18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Preoperative F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value Predicts Survival After Lung Cancer ResectionJournal of Clinical Oncology, 2004
- Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative reviewThe Lancet Oncology, 2001
- Anatomy of SUVNuclear Medicine and Biology, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendationsEuropean Journal Of Cancer, 1999
- The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor modelsNuclear Medicine and Biology, 1996
- Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomographyThe Annals of Thoracic Surgery, 1995
- Biologic and Molecular Prognostic Factors—Impact on Treatment of Patients With Non-small Cell Lung CancerChest, 1995